Chemical reprogramming of human blood cells to pluripotent stem cells

Cell Stem Cell. 2025 Aug 7;32(8):1192-1199.e11. doi: 10.1016/j.stem.2025.07.003. Epub 2025 Jul 30.

Abstract

Chemical reprogramming offers a fundamentally innovative approach for generating human chemically induced pluripotent stem (hCiPS) cells using small molecules. Our recent studies showed that this approach was highly efficient in reprogramming human fibroblasts to hCiPS cells. However, generating hCiPS cells from human blood cells, which are the most accessible and convenient source for reprogramming, remains a challenge. In this study, we established a robust method that successfully generated hCiPS cells from both cord blood and adult peripheral blood cells. This method achieved efficient reprogramming with both fresh and cryopreserved blood cells across different donors. Notably, this method also efficiently generated an average of over 100 hCiPS colonies from just a single drop of fingerstick blood. These results highlight the advantages of chemical reprogramming for generating hCiPS cells from a blood source and represent a next-generation platform for efficient, scalable, and convenient stem cell production with broad applications in regenerative medicine.

Keywords: adult peripheral blood; chemical reprogramming; hCiPS cells; human cord blood; pluripotency; small molecules.

MeSH terms

  • Adult
  • Blood Cells* / cytology
  • Blood Cells* / drug effects
  • Blood Cells* / metabolism
  • Cell Differentiation
  • Cells, Cultured
  • Cellular Reprogramming* / drug effects
  • Fetal Blood / cytology
  • Fibroblasts / cytology
  • Humans
  • Induced Pluripotent Stem Cells* / cytology
  • Induced Pluripotent Stem Cells* / drug effects
  • Induced Pluripotent Stem Cells* / metabolism
  • Pluripotent Stem Cells* / cytology